EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Biomimetic nanomedicines for precise atherosclerosis theranostics

Ying Tao, Xinmiao Lan, Yang Zhang, Chenxing Fu, Lu Liu, Feng Cao, Weisheng Guo

Acta Pharmaceutica Sinica B · 2023-11 · 13 (11) · 4442-4460

DOI: 10.1016/j.apsb.2022.11.014 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Pharmaceutica Sinica B, 2023-11. Verfasst von Ying Tao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Minimally Invasive Interventional Radiology, Key Laboratory of Molecular Target & Clinical Pharmacology, School of Biomedical Engineeri…. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 196 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: China Association for Science and Technology, National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerosis (AS) is a leading cause of the life-threatening cardiovascular disease (CVD), creating an urgent need for efficient, biocompatible therapeutics for diagnosis and treatment. Biomimetic nanomedicines (bNMs) are moving closer to fulfilling this need, pushing back the frontier of nano-based drug delivery systems design. This review seeks to outline how these nanomedicines (NMs) might work to diagnose and treat atherosclerosis, to trace the trajectory of their development to date and in the coming years, and to provide a foundation for further discussion about atherosclerotic theranostics.

Schlagwörter

Stichwörter der Autor:innen

Active targetingAtherosclerosisBiomimetic nanomedicinesDiagnosis and treatmentDrug deliveryNanotheranosticsPassive targetingPlaques

Autor:innen und Institutionen

  • Department of Minimally Invasive Interventional Radiology, Key Laboratory of Molecular Target & Clinical Pharmacology, School of Biomedical Engineering & the Second Affiliated Hospital, Guangzhou Medical University, Gua…
  • School of Pharmaceutical Sciences, Capital Medical University, Beijing 100069, China.
  • Department of Cardiology, the Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing 100853, China.
  • Department of Cardiology and Laboratory of Heart Center, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China.
  • Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, the University of Hong Kong, Hong Kong SAR 999077, China.

Förderung

  • China Association for Science and Technology
  • National Natural Science Foundation of China
  • Natural Science Foundation of Guangdong Province
  • Department of Education of Guangdong Province

Zitieren

APA

Tao, Y., Lan, X., Zhang, Y., Fu, C., Liu, L., Cao, F., & Guo, W. (2023). Biomimetic nanomedicines for precise atherosclerosis theranostics. Acta Pharmaceutica Sinica B, 13(11), 4442-4460. https://doi.org/10.1016/j.apsb.2022.11.014

Vancouver

Tao Y, Lan X, Zhang Y, Fu C, Liu L, Cao F, et al. Biomimetic nanomedicines for precise atherosclerosis theranostics. Acta Pharmaceutica Sinica B. 2023;13(11):4442-4460. doi:10.1016/j.apsb.2022.11.014

BibTeX
@article{Tao2023,
  author = {Tao, Ying and Lan, Xinmiao and Zhang, Yang and Fu, Chenxing and Liu, Lu and Cao, Feng and Guo, Weisheng},
  title = {Biomimetic nanomedicines for precise atherosclerosis theranostics},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2023},
  volume = {13},
  number = {11},
  pages = {4442--4460},
  doi = {10.1016/j.apsb.2022.11.014}
}
Kostenlos starten →